Union minister Mansukh Mandaviya announced yesterday that the government has approved Bharat Biotech’s Ankleshwar-based manufacturing plant to produce the COVID-19 vaccine Covaxin. “Govt of India approves vaccine manufacturing facility in Ankleshwar, Gujarat for production of @BharatBiotech’s #Covaxin,” Mandaviya tweeted.
The approval would help increase availability of COVID-19 vaccines in the country, he added.
“Following PM @NarendraModi ji’s vision of #SabkoVaccineMuftVaccine, this will increase vaccine availability & accelerate the world’s largest vaccine drive,” the minister who heads both Chemicals and Fertilisers and Health ministries, noted.
In May this year, Bharat Biotech had announced that it plans to produce an additional 200 million doses of Covaxin at its Ankleshwar-based facility.
The Hyderabad-based firm had noted that it would utilise the manufacturing plant of its wholly-owned unit – Chiron Behring, to add another 200 million doses of Covaxin.
Choking is a leading cause of injury and death in young children, particularly those under…
Hard Water (Khara Pani) Leading To Hair Fall Hard water is rich in minerals and…
Discover how the rise in high blood pressure during pregnancy is impacting maternal and fetal…
"Discover the transformative power of six delicious homemade drinks that can help you naturally melt…
"Transform your weight loss routine with these eight delicious fat-flushing drinks that not only hydrate…
"Is your sweet tooth taking a toll on your health? Discover the key signs that…